TREATMENT APPROACHES

Anticholinergics in the Management of DRBA-Induced Movement Disorders

Review the role of anticholinergics across common dopamine receptor-blocking agent (DRBA)-induced movement disorders, including key pathophysiologic differences, appropriate use in conditions such as drug-induced parkinsonism and dystonia, and the inappropriate use for the treatment of tardive dyskinesia.
Empty space, drag to resize
Up Next
The Inappropriate Use of Anticholinergics in Tardive Dyskinesia
Explore why anticholinergics are not recommended for the treatment of tardive dyskinesia (TD), the importance of reducing anticholinergic burden when appropriate, and the key pharmacologic differences among common treatment strategies for TD.
Up Next
EXPLORE OUR FOCUS ON VMAT2 INHIBITORS PATH
Want to learn more about treating tardive dyskinesia? Follow this path to learn about the mechanism of action and pharmacology of VMAT2 inhibitors.

Your Resources on Tardive Dyskinesia and Other DIMDs

These free educational resources are sponsored and developed by Neurocrine Biosciences, Inc.
Discover TD®
In this interactive application, users can differentially diagnose and develop appropriate management plans for hypothetical, virtual patients with various movement disorders.
DIMD Course
Enroll in this free, virtual self-paced learning platform delving into various clinical aspects of the most common DRBA-induced movement disorders and earn a recognized certificate of completion. 

Media Platforms

TD Dialogues® Podcast
Hear from experts in insightful conversations as they discuss the challenges of recognizing TD and share real-world strategies to effectively support patients in managing symptoms.
Neurocrine Medical: Brave Science™ YouTube Channel
This channel features educational videos designed to further understanding of TD, including content on the proposed mechanism of disease in TD and differentiating TD from drug-induced parkinsonism.

Explore the DIMD Ecosystem Library

Want to explore our collection of DIMD educational resources on your own? Use the link below to view the full content library.
This educational content was sponsored and developed by Neurocrine Biosciences, Inc. This non-CME program is intended to provide general information about drug-induced movement disorders and not medical advice for any particular patient.

Copyright © 2026

MED-MI-TD-US-0276